Development and efficacy of mobile application to improve medication adherence for persons with cardiac disease.

IF 0.5 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS

ARYA Atherosclerosis Pub Date : 2024-01-01 DOI:10.48305/arya.2024.42169.2924

Raziyeh Ghafouri, Roxana Karbaschi, AliReza Mashhadi Hosein, Shakila Sharifian

{"title":"Development and efficacy of mobile application to improve medication adherence for persons with cardiac disease.","authors":"Raziyeh Ghafouri, Roxana Karbaschi, AliReza Mashhadi Hosein, Shakila Sharifian","doi":"10.48305/arya.2024.42169.2924","DOIUrl":null,"url":null,"abstract":"Background: Patients with cardiovascular disease need to adhere to their treatment and care recommendations to prevent the progression of their condition and improve their quality of life. In this regard, this study was conducted to develop a mobile application and test its effectiveness in improving medication adherence among persons with cardiac disease.Methods: The study was conducted in two stages. The first stage involved the preparation of the \"Mobile Application for Persons with Cardiac Disease\" using the cascade model. In the second stage, 121 patients who were hospitalized in the cardiac intensive care unit of Ayatollah Taleghani Medical Education Center of Tehran from March to August 2023 were enrolled. The participants were randomly assigned to either the control group (63 people) or the intervention group (58 people). The study collected data using a medication adherence questionnaire on the 7th, 14th, and 21st day after discharge and compared the results with the control group. The data were analyzed using SPSS 20.Results: The average age of the control group was 56.75 ± 11.38 years, and the average age of the intervention group was 57.03 ± 11.55 years. The comparison of the average medication adherence with independent t-tests showed a significant difference between the intervention and control groups on the 7th, 14th, and 21st day after discharge (P<0.01). The results of the repeated measures test in each group also showed that the difference between the groups increased over time (P<0.001).Conclusion: The results of the study showed that the mobile application is effective in improving medication adherence among heart patients.","PeriodicalId":46477,"journal":{"name":"ARYA Atherosclerosis","volume":"20 3","pages":"28-36"},"PeriodicalIF":0.5000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11651310/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ARYA Atherosclerosis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.48305/arya.2024.42169.2924","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Patients with cardiovascular disease need to adhere to their treatment and care recommendations to prevent the progression of their condition and improve their quality of life. In this regard, this study was conducted to develop a mobile application and test its effectiveness in improving medication adherence among persons with cardiac disease.

Methods: The study was conducted in two stages. The first stage involved the preparation of the "Mobile Application for Persons with Cardiac Disease" using the cascade model. In the second stage, 121 patients who were hospitalized in the cardiac intensive care unit of Ayatollah Taleghani Medical Education Center of Tehran from March to August 2023 were enrolled. The participants were randomly assigned to either the control group (63 people) or the intervention group (58 people). The study collected data using a medication adherence questionnaire on the 7th, 14th, and 21st day after discharge and compared the results with the control group. The data were analyzed using SPSS 20.

Results: The average age of the control group was 56.75 ± 11.38 years, and the average age of the intervention group was 57.03 ± 11.55 years. The comparison of the average medication adherence with independent t-tests showed a significant difference between the intervention and control groups on the 7th, 14th, and 21st day after discharge (P<0.01). The results of the repeated measures test in each group also showed that the difference between the groups increased over time (P<0.001).

Conclusion: The results of the study showed that the mobile application is effective in improving medication adherence among heart patients.

查看原文本刊更多论文

提高心脏病患者服药依从性的移动应用程序的开发和疗效。

背景：心血管疾病患者需要坚持他们的治疗和护理建议，以防止病情的进展，提高他们的生活质量。在这方面，本研究是为了开发一个移动应用程序，并测试其在改善心脏病患者服药依从性方面的有效性。方法：研究分为两个阶段进行。第一阶段涉及使用级联模型编制“心脏病患者移动应用程序”。在第二阶段，纳入了2023年3月至8月在德黑兰阿亚图拉塔莱格尼医学教育中心心脏重症监护病房住院的121名患者。参与者被随机分配到对照组（63人）或干预组（58人）。本研究于出院后第7、14、21天采用药物依从性问卷收集数据，并与对照组进行比较。数据采用SPSS 20进行分析。结果：对照组患者平均年龄56.75±11.38岁，干预组患者平均年龄57.03±11.55岁。通过独立t检验比较干预组与对照组在出院后第7、14、21天的平均服药依从性差异有统计学意义(p)。结论：研究结果表明，移动应用程序对改善心脏病患者的服药依从性是有效的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊